Zhejiang Doer Biologics Co.,Ltd.

About Doer Biologics 

Founded in 2014, Zhejiang Doer Biologics Co., Ltd is a 

clinical-stage biopharmaceutical company with its R&D 

center located in Hangzhou, China. Powered by its 

proprietary xLONGylation, MultipleBody, AccuBody, 

and SMART-VHHBody technology platforms,  Doer 

Biologics is developing innovative multi-domain based 

multi-specific therapeutic proteins. Doer Biologics' 

highly differentiated pipeline focuses on unmet clinical 

needs in the fields of cancer, endocrinology, metabolic 

diseases, and ophthalmology. To learn more about Doer 

Biologics, please visit the company website:  

http://doerbio.com/